OPNT - Opiant Pharmaceuticals GAAP EPS of -$2.31 misses by $0.95 revenue of $3.89M misses by $0.77M August, 11 2022 04:39 PM Opiant Pharmaceuticals Inc. Opiant Pharmaceuticals press release ( NASDAQ: OPNT ): Q2 GAAP EPS of -$2.31 misses by $0.95 . Revenue of $3.89M (-65.5% Y/Y) misses by $0.77M . For further details see: Opiant Pharmaceuticals GAAP EPS of -$2.31 misses by $0.95, revenue of $3.89M misses by $0.77M